Catalyst Wire Dossier Catalyst Wire Dossier

CelluJuve®

· Spiderwort Biotechnologies Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CelluJuve®, covering 2025-04-20 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: CelluJuve® for the Treatment of Moderate to Severe NLFs [NA]

See pricing